Switzerland and Ireland work together in the therapeutic products sector

Bern, 27.10.2011 - Switzerland and Ireland wish to work more closely together in the therapeutic products sector. The Federal Council has approved a corresponding agreement, and Swissmedic, the Swiss Agency for Therapeutic Products, and the Irish Medicine Board (IMB) have signed it today.

The signed agreement is the first bilateral co-operation arrangement between Swissmedic, the Swiss Agency for Therapeutic Products and a national regulatory authority of an EU Member State. It was initiated by Ireland. The agreement is not legally binding, and is a so-called Memorandum of Understanding.
This collaboration is of interest to both countries because the Swiss and Irish therapeutics products authorities are comparable. Both – compared to their size – have a significant pharmaceutical industry that is regulated by the IMB and Swissmedic respectively.

Among the objectives of this Memorandum of Understanding is the possibility of exchanging information and documents, and thus fostering understanding of the regulatory framework. The collaboration should make it possible for both authorities to fulfil their mandate more effectively.


Address for enquiries

Swissmedic, Swiss Agency for
Therapeutic Products,
Daniel Lüthi, Head of Press Relations,
Tel. 031/ 322 02 76


Publisher

The Federal Council
https://www.admin.ch/gov/en/start.html

Swiss Agency for Therapeutic Products
http://www.swissmedic.ch/?lang=2

https://www.admin.ch/content/gov/en/start/dokumentation/medienmitteilungen.msg-id-41934.html